[1]
W. Rajabto, B. Brahma, R. I. Putri, H. Indrawati, and A. Safitri, “Dual Anti-HER2 Combination with Chemotherapy as First-line Treatment for HER2-positive Metastatic Breast Cancer”, Acta Med Indones, vol. 57, no. 4, p. 538, Dec. 2025.